Sweden Country Report 2013

Presented by

Discovery Reports

SHL stays ahead of health care and biotech revolution

PUBLISHED : Tuesday, 15 October, 2013, 12:48pm
UPDATED : Tuesday, 15 October, 2013, 12:49pm

Recognised for its significant contributions to the global health care industry, SHL Group combines Swedish technological innovation and design with the manufacturing strengths and skilled workforce of Greater China.

The world's largest privately owned designer, developer and manufacturer of drug-delivery systems, SHL has earmarked HK$310 million this year to expand production facilities in Taiwan. It operates nine production centres in Taiwan, one on the mainland and in the United States. SHL's top-notch facilities guarantee continuous production flow and quality control.

The company creates machinery for production, automation, tooling, assembly, in-house moulding, welding, fabricating, sewing, metrology and much more.

"Our specialised tooling engineers design tools for manufacturing parts and equipment," says Ake Karlson, managing director of SHL Healthcare, one of the group's subsidiaries. SHL synergises the strengths of each subsidiary, which also includes SHL Medical, SHL Technologies, SHL Pharma and SHL Ventures.

A committed partner of global brands such as Handicare and Invacare, SHL Healthcare manufactures medical slings for patients with limited mobility. Its innovative alternating pressure mattress systems prevent and treat pressure sores. Other products include rehabilitation beds, medical soft goods and advanced drug-delivery devices such as auto-injectors and pen injectors.

Working with leading biopharmaceutical companies, SHL Healthcare benefits from SHL Medical's expertise as the market leader in auto-injector technology.

With enhanced safety features and novel designs, SHL's devices, such as its patented Disposable Auto Injector, have become benchmarks within the industry.

Pen injectors, such as the Precision Pen Injector, are designed for small but highly accurate doses while still being able to deliver a highly viscous medication.

SHL hones its expertise in customising health care system solutions through close collaboration with clients. It maintains research and development facilities in Sweden, the US, Taiwan and on the mainland.

To assure continued success, SHL seeks partners with local expertise. "We are looking for local suppliers with reliable delivery performance and quality to help us meet market requirements and to support SHL Heathcare operations," Karlson says.


SHL Healthcare